TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/06 18:31 | 5/22/06 | OSCI | Oscient Pharmaceuticals Corp | MA | Health | Drug | Pharmaceutical Preparations | Cohen Stephen | MA | O | SVP,CFO | P | 19 | 1.29 | 0 | 15 | 17 | 102 | |||||||||||||||
12/14/05 18:26 | 12/12/05 | OSCI | Oscient Pharmaceuticals Corp | MA | Health | Drug | Pharmaceutical Preparations | Cohen Stephen | MA | O | SVP,CFO | P | 2 | 2.18 | 0 | 1 | 83 | 2 | I | ||||||||||||||
5/20/05 15:15 | 5/19/05 | OSCI | Oscient Pharmaceuticals Corp | MA | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Stephen | MA | O | SVP,CFO | P | 21 | 1.91 | 0 | 11 | 40 | 38 | D | ||||||||||||||
12/17/04 14:45 | 12/15/04 | OSCI | Oscient Pharmaceuticals Corp | MA | Health | Diagn | In Vitro & In Vivo Diagnostic | Cohen Stephen | MA | O | SVP,CFO | S | -2 | 3.57 | 0 | -1 | -30 | 1 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |